Skip to content

Treatment of NAFLD With Two Different Diets

Treatment of NAFLD With Two Different Diets

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03118310
Acronym
TREND
Enrollment
74
Registered
2017-04-18
Start date
2017-04-06
Completion date
2020-08-31
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD

Keywords

Reduction of liver fat

Brief summary

The impact of popular diets on liver-related health is unclear. In this randomized, controlled trial, patients with NAFLD will be randomized to one of two popular diets or a placebo diet.

Detailed description

Subjects will include patients with MRI-verified NAFLD, with no concurrent liver diseases. Randomization will be done to either a control diet, the 5:2 diet or a low-carb-high-fat diet. The subjects will follow the diet for three months, after which a new MRI is performed. Main outcomes measure is reduction in liver fat.

Interventions

BEHAVIORAL5:2 diet

Dietary intervention according to 5:2 diet during three months.

BEHAVIORALLCHF

Dietary intervention according to LCHF diet during three months.

BEHAVIORALPlacebo diet

Placebo diet: normal dietary advice

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Known NAFLD

Exclusion criteria

* Other forms of liver disease * Bolus insulin treatment * Cirrhosis

Design outcomes

Primary

MeasureTime frameDescription
Liver fatThree monthsMRI-measured liver fat content

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026